News from alere inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Apr 06, 2015, 16:05 ET

Alere Inc. Reports Employment Inducement Awards Pursuant to NYSE Rule 303A.08

 Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, announced today, pursuant to NYSE Rule 303A.08, that it has granted, or will...

Apr 02, 2015, 07:00 ET

Alere Receives FDA Clearance for Alere™ i Strep A Rapid Molecular Test

Alere Inc. (NYSE: ALR), a global leader in rapid diagnostic tests, today announced that its Alere™ i Strep A test has received marketing...

Mar 30, 2015, 07:00 ET

Alere Applauds President's National Action Plan to Combat Antibiotic-Resistant Bacteria

Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, issued the following statement today in support of President Barack Obama's National...

Mar 23, 2015, 07:00 ET

Alere to Appoint Veteran Finance Executive, James F. Hinrichs, EVP and Chief Financial Officer

Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, today announced that James F. ("Jim") Hinrichs will be appointed Executive Vice...

Mar 09, 2015, 16:30 ET

Alere Announces Chief Financial Officer Transition

 Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, today announced that David Teitel, the Company's Chief Financial Officer (CFO),...

Mar 05, 2015, 16:05 ET

Alere Inc. to Host Investment Community Meeting

 Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, will hold an investment community meeting in New York, NY on Thursday, March...

Mar 03, 2015, 07:00 ET

Alere Inc. Declares Cash Dividend on its Series B Convertible Perpetual Preferred Stock

Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, today has declared a cash dividend of $3.00 per share on its Series B Convertible...

Mar 02, 2015, 07:00 ET
Alere Receives IVD CE Mark for Alere(TM) q HIV-1/2 Detect Assay for Molecular Diagnosis of HIV at the Point of Care

Alere Receives IVD CE Mark for Alere™ q HIV-1/2 Detect Assay for Molecular Diagnosis of HIV at the Point of Care

 Alere Inc. (NYSE: ALR), a global leader in rapid diagnostic tests, today announced it has received IVD CE marking in Europe for the Alere q...

Feb 23, 2015, 07:00 ET

Alere to Present at 35th Annual Cowen and Company Health Care Conference

 Alere Inc. (NYSE: ALR), a global leader in rapid diagnostic tests, today announced that CEO and President Namal Nawana will present at the...

Feb 10, 2015, 07:00 ET

Alere Inc. Announces Fourth Quarter 2014 Results

 Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, announced its financial results for the quarter ended December 31, 2014. Namal...

Feb 03, 2015, 17:55 ET

Alere Schedules Fourth Quarter 2014 Earnings Conference Call

 Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, today announced that it will release its financial results for the fourth...

Jan 09, 2015, 16:10 ET

Alere Inc. Completes Divestiture of Alere Health

 Alere Inc. (NYSE: ALR) today announced the completion of the previously announced sale of Alere Health and its subsidiaries, which provide...

Jan 07, 2015, 07:00 ET
First-ever CLIA-waived molecular flu test delivers lab-accurate results at the point of care in less than 15 minutes

Alere Receives FDA CLIA Waiver for Alere™ i Influenza A & B Test

 Alere Inc. (NYSE: ALR), a global leader in rapid diagnostic tests, today announced that the U.S. Food and Drug Administration (FDA) has...

Jan 05, 2015, 07:00 ET

Alere to Present at 33rd Annual J.P. Morgan Healthcare Conference

 Alere Inc. (NYSE: ALR), a global leader in rapid diagnostic tests, today announced that CEO and President Namal Nawana will present at the...

Dec 10, 2014, 17:30 ET

Alere Inc. Declares Cash Dividend on its Series B Convertible Perpetual Preferred Stock

Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, today has declared a cash dividend of $3.00 per share on its Series B Convertible...

Dec 09, 2014, 07:00 ET

U.S. Food and Drug Administration Grants CLIA Waiver for Alere Determine™ HIV-1/2 Ag/Ab Combo Test

Alere Inc. (NYSE: ALR), a global leader in rapid diagnostic tests, today announced that the U.S. Food and Drug Administration (FDA) has granted...

Dec 08, 2014, 07:00 ET

Alere Initiates Voluntary URGENT CORRECTION for Use of Alere INRatio® and INRatio®2 PT/INR Monitor System

 Alere Inc. (NYSE:ALR) has initiated a voluntary correction to inform U.S. users of the Alere INRatio® and INRatio®2 PT/INR Monitor...

Nov 21, 2014, 08:30 ET

Alere Appoints Juliet Cunningham to Lead Investor Relations

 Alere Inc. (NYSE: ALR), a global leader in rapid diagnostic tests, has appointed Juliet Cunningham as Vice President, Investor Relations. In...

Nov 18, 2014, 15:34 ET

Alere to Participate in Jefferies Global Healthcare Conference

 Alere Inc. (NYSE: ALR), a global leader in rapid diagnostic tests, announced that it will participate in the Jefferies Global Healthcare...

Nov 14, 2014, 09:00 ET

Malaria No More Honors Alere's Contributions to Diagnosing and Eliminating Malaria in sub-Saharan Africa

Alere Inc. (NYSE: ALR), a global leader in rapid diagnostic tests, has been honored for its leadership in the fight against malaria with a...